Woodcliff Lake, New Jersey, United States Merck Capital Ventures is the famous VC, which was founded in 2000. The main office of represented VC is situated in the Woodcliff Lake. The venture was found in North America in United States.
Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2015. The important activity for fund was in 2008. Comparing to the other companies, this Merck Capital Ventures performs on 13 percentage points more the average number of lead investments.
This organization was formed by Per Lofberg.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Merck Capital Ventures, startups are often financed by Solstice Capital, Valley Ventures, Piper Jaffray. The meaningful sponsors for the fund in investment in the same round are Valley Ventures, Solstice Capital, SR One. In the next rounds fund is usually obtained by SR One, Valley Ventures, Solstice Capital.
The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Artios Pharma, ImpactRx, VisEn Medical For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Genetics, Health Care.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anna Partners | Israel, Tel Aviv, Tel Aviv District |
| Athaal Group | Jeddah, Makkah, Saudi Arabia |
| Corl | Canada, Ontario, Toronto |
| Dingxin Ruitong | Beijing, China, Fengtai |
| Doughty Hanson & Co | England, London, United Kingdom |
| Fernbrook Capital Management LLC | New York, New York, United States |
| FOCUS Japan | Japan, Tokyo |
| Goldman Sachs Asset Management | New York, New York, United States |
| Impacton | - |
| Land Hessen | - |
| Newbridge Andean Partners | Argentina, Buenos Aires, Distrito Federal |
| Ritchie Bros | British Columbia, Burnaby, Canada |
| SFP Capital | Maryland, Severna Park, United States |
| Sharp Eye Capital | - |
| Shinsei Corporate Investment Limited | Chiyoda, Japan |
| Sungy Mobile | China, Guangdong, Guangzhou |
| Swiss Investment group | - |
| TKC Capital | California, El Segundo, United States |
| Whalehaven Capital Fund | Canada, Ontario, Toronto |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
She's Well | $2M | 25 Oct 2019 | San Francisco, California, United States | ||
Artios Pharma | $89M | 10 Aug 2018 | Cambridge, England, United Kingdom | ||
Spero Therapeutics | $30M | 08 Jun 2015 | Cambridge, Massachusetts, United States | ||
HTG Molecular Diagnostics | $2M | 28 Nov 2008 | Tucson, Arizona, United States | ||
VisEn Medical | $5M | 21 Apr 2008 | Massachusetts, United States | ||
HTG Molecular Diagnostics | $5M | 08 Oct 2007 | Tucson, Arizona, United States | ||
ImpactRx | $3M | 08 Jul 2003 | New Jersey, United States | ||
Acurian | $27M | 28 Mar 2001 | Horsham Township, Pennsylvania, United States | ||
Acurian | $6M | 01 Dec 1998 | Horsham Township, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
She's Well | $2M | 25 Oct 2019 | San Francisco, California, United States | ||
Artios Pharma | $89M | 10 Aug 2018 | Cambridge, England, United Kingdom | ||
Spero Therapeutics | $30M | 08 Jun 2015 | Cambridge, Massachusetts, United States | ||
HTG Molecular Diagnostics | $2M | 28 Nov 2008 | Tucson, Arizona, United States | ||
VisEn Medical | $5M | 21 Apr 2008 | Massachusetts, United States | ||
HTG Molecular Diagnostics | $5M | 08 Oct 2007 | Tucson, Arizona, United States | ||
ImpactRx | $3M | 08 Jul 2003 | New Jersey, United States | ||
Acurian | $27M | 28 Mar 2001 | Horsham Township, Pennsylvania, United States | ||
Acurian | $6M | 01 Dec 1998 | Horsham Township, Pennsylvania, United States |
